Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2019 Dec;49(12):2204-2221.
doi: 10.1002/eji.201948223. Epub 2019 Aug 16.

Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients

Affiliations
Free article
Clinical Trial

Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients

Sara De Biasi et al. Eur J Immunol. 2019 Dec.
Free article

Abstract

Patients with primary progressive (PP) and secondary progressive (SP) forms of multiple sclerosis (MS) exhibit a sustained increase in the number of Th1, T cytotoxic type-1 and Th17 cells in peripheral blood, suggesting that the progressive phase is characterized by a permanent peripheral immune activation. As T cell functionality and activation are strictly connected to their metabolic profile, we investigated the mitochondrial functionality and metabolic changes of T cell subpopulations in a cohort of progressive MS patients. T cells from progressive patients were characterized by low proliferation and increase of terminally differentiated/exhausted cells. T cells from PP patients showed lower Oxygen Consumption Rate and Extracellular Acidification Rate, lower mitochondrial mass, membrane potential and respiration than those of SP patients, a downregulation of transcription factors supporting respiration and higher tendency to shift towards glycolysis upon stimulation. Furthermore, PP effector memory T cells were characterized by higher Glucose transporter -1 levels and a higher expression of glycolytic-supporting genes if compared to SP patients. Overall, our data suggest that profound differences exist in the phenotypic and metabolic features of T cells from PP and SP patients, even though the two clinical phenotypes are considered part of the same disease spectrum.

Keywords: T cells; flow cytometry; metabolism; mitochondria; multiple sclerosis.

PubMed Disclaimer

References

    1. Leray, E., Yaouanq, J., Le Page, E., Coustans, M., Laplaud, D., Oger, J. and Edan, G., Evidence for a two-stage disability progression in multiple sclerosis. Brain 2010. 133: 1900-1913.
    1. Mallucci, G., Peruzzotti-Jametti, L., Bernstock, J. D. and Pluchino, S., The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis. Prog Neurobiol 2015. 127-128: 1-22.
    1. Frisullo, G., Plantone, D., Marti, A., Iorio, R., Damato, V., Nociti, V., Patanella, A. K. et al., Type 1 immune response in progressive multiple sclerosis. J Neuroimmunol 2012. 249: 112-116.
    1. Zastepa, E., Fitz-Gerald, L., Hallett, M., Antel, J., Bar-Or, A., Baranzini, S., Lapierre, Y. et al., Naive CD4 T-cell activation identifies MS patients having rapid transition to progressive MS. Neurology 2014. 82: 681-690.
    1. De Biasi, S., Simone, A. M., Nasi, M., Bianchini, E., Ferraro, D., Vitetta, F., Gibellini, L. et al., iNKT cells in secondary progressive multiple sclerosis patients display pro-inflammatory profiles. Front Immunol 2016. 7: 555.

Publication types

Substances

LinkOut - more resources